Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|June 12, 2025
A phase II trial of palbociclib plus letrozole after progression on second-line chemotherapy for women with hormone receptor-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer (LACOG 1018)Fernanda Bronzon Damian, Andreia Cristina De Melo, Graziela Z Dal Molin, et al.
Breast Care (Basel, Switzerland)|March 6, 2025
Patient Preferences for HR+/HER2- Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice ExperimentVictoria Harmer, Cathy Ammendolea, Mandy Ryan, et al.
Journal of Global Oncology|November 27, 2019
Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational StudyMax S Mano, Rafaela Gomes, Gustavo Werutsky, et al.
Therapeutic Advances in Medical Oncology|February 7, 2025
TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2- breast cancerHeather L McArthur, Sara M Tolaney, Rebecca Dent, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phaseEmiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
Oncology and Therapy|June 3, 2024
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell LymphomaMarcia Torresan Delamain, Ana Carolina Ferreira Cardoso, Fernando Vieira Pericole, et al.
The Lancet. Oncology|November 4, 2021
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the CaribbeanGustavo Werutsky, Carlos H Barrios, Andres F Cardona, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trialsGustavo Werutsky, Michael Untch, Claus Hanusch, et al.
BMC Cancer|May 25, 2019
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levelsGustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, et al.
JCO Global Oncology|April 11, 2024
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira StudyDaniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, et al.
Pageof 9